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Abstract. Indonesia presently has the fourth largest diabetic mellitus prevalence 
of all countries in the world. In a previous study, a mixture extract of Piper 
crocatum leaves and Cinnamomum burmannii bark showed in vitro 
antihyperglycemic activity. It acted as inhibitor of the -glucosidase enzyme and 
had no toxic effect when it was administered orally to male and female rats for 
28 days. In the present study, mixture extracts of P. crocatum leaves and C. 
burmannii bark were used to observe antihyperglycemic activity in diabetic rats 
induced with streptozotocin. Mixture extracts of P. crocatum leaves and C. 
burmannii bark were orally given to diabetic Sprague Dawley rats at various 
doses for 16 days. The results showed that the treatment led to a reduction of the 
blood glucose level, an increase in blood insulin level up to 170.75% at 1260 
mg/kg body weight, maintaining the blood lipid level of the diabetic rats at a 
normal level, and an increase of pancreatic ß cells in the islets of Langerhans up 
to 2.2-fold at 1260 mg/kg body weight. The mixture extracts of P. crocatum and 
C. burmannii have antihyperglycemic activity, which enhances the number of 
pancreatic β cells. 
Keywords: antihyperglycemic agents; Cinnamomum burmannii; glucose; insulin; lipid 
profile; Piper crocatum. 
1 Introduction 
Hyperglycemia, or a high blood glucose level, is an indication of diabetes 
mellitus. It is a metabolic syndrome that is caused by disruption of the insulin 
hormone. Chronic hyperglycemia can lead to imbalances in the body, such as 
damage to eyes, kidneys and other organs [1]. The increase of the number of 
people with diabetics based on statistical projections from the years 2000 to 
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2010 will reach about 70 million in Indonesia in 2050. Indonesia has the highest 
diabetic prevalence after India, China and the USA [2,3]. 
Using traditional medicines that come from plants has been a priority for 
antihyperglicemic agents because they are more advantegeous than modern 
drugs [4]. Traditionally, in diabetic treatment, people used decoctions of Piper 
crocatum (Piperaceae). According to a previous study [5], a ten-day treatment 
with various doses of decoctions of P. crocatum extract reduced the blood 
glucose level up to 10-38%. A phytochemical assay of P. crocatum showed that 
the decoction contained alkaloids, flavonoids and tannins [5]. These are known 
to be bioactive antidiabetic and antioxidant compounds [6-8]. P. crocatum 
extract has a bitter taste. It can be combined with Cinnamomum burmannii in 
order to obtain a more acceptable flavor and help preserve the product, because 
C. burmannii has antibacterial and antibiotic activity. 
Cinnamomum burmannii is inhibitory against pathogenic microorganisms with 
high activity. This can be seen from the diameter of the clear zones of each 
bacteria (mm). These are 15.4 mm (B. cereus), 11.5 mm (L. monocytogenes), 
15.7 mm (S. aureus), 8.7 mm (E. coli) and 12.1 mm (S. anatum). Further, it also 
has antioxidant capacity (107.7 mmol trolox/100 g dry weight) [9]. Cinnamon 
has many benefits in food preparation with its unique flavor and taste. Besides 
that, it may play a role in the regulation of blood pressure and glucose 
metabolism, i.e. it can contribute to the uptake of glucose into cells [10]. It has 
been reported that giving cinnamon at different doses per day has beneficial 
effects for type 2 diabetic patients, such as reduction of the blood glucose level 
and cholesterol in the body [11]. The present study was conducted to observe 
the effects of mixture extracts of P. crocatum and C. burmannii as 
antihyperglycemic agents in diabetic rats induced by streptozotocin. 
2 Methods 
2.1 Functional Food Preparation of P. crocatum and C. burmannii 
P. crocatum and C. burmannii were collected from the Indonesian Medicinal 
and Aromatic Crops Research Institute (IMACRI). The material was identified 
in the Herbarium Bogoriense, Indonesian Institute of Sciences (LIPI), Bogor. 
Dried leaves of P. crocatum (10 g) were boiled in water (200 mL); boiling was 
terminated when the volume reached 100 mL. Dried bark of C. burmannii (20 
g) was boiled in water (200 mL); boiling was terminated when the volume 
reached 200 mL. The extract that was obtained from filtering with Whatman 
filter paper number 4 was used for further assays. The P. crocatum extract was 
mixed with the C. burmannii extract at a ratio of 1:0.6, after which it was added 
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with an amount of stevia (0.67 % v/v) as natural sweetener with a low glycemic 
index. 
2.2 Experimental Animals 
Sprague Dawley male and female rats (210-260 g) were obtained from the 
experimental animal facility of the National Agency of Drugs and Food Control 
(BPOM), Republic of Indonesia. The rats were fed with standard pellet diet 
during the experiment (CP Rodent, Thailand; 18% protein, 3% fat, 13% water, 
10% ashes, 9% fiber, 9000 IU/kg vitamin A, 1800 IU/kg vitamin D3, 80 IU/kg 
vitamin E, and 800 mg/kg vitamin C). Randomized rats were acclimatized for 7 
days in 24 ± 1 ºC with a light:dark cycle of 12 hours and a relative humidity of 
55-75%. The Institutional Animal Ethics Committee (PT. Bimana Indomedical 
R.02-11-IR) gave clearance for the use of the test animals in this study. 
2.3 Experimental Design 
There were 6 experimental groups, which were randomly obtained from 24 
Sprague Dawley rats (210-260 g), i.e. group KN – normal control (administered 
intraperitoneally (i.p.) with NaCl 0.9% and orally (p.o.) with aquadest 2 mL per 
day for 16 days); group KP – diabetic control (administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with aquadest 2 mL per day for 
16 days); groups KDS 1, KDS 2, and KDS 3 were given the mixture extract 
treatment at different doses (administered i.p. with streptozotocin 50 mg/kg 
body weight and p.o. with extract 630 mg/kg body weight (KDS 1), 1260 mg/kg 
body weight (KDS 2), and 1890 mg/kg body weight (KDS 3)); group SM was 
administered i.p. with streptozotocin 50 mg/kg body weight and p.o. with 
P. crocatum extract 1350 mg/kg body weight. 
Observation of the rats’ body weight and food consumption was conducted on 
days 1, 3 and 16. Rats that had been induced with streptozotocin for 48 hours 
were used for testing the mixture extract. Blood sampling from the tail vein of 
the rats was conducted on the rats that were left fasting for 18 hours. The 
instrument used for measuring the blood glucose level was an electronic 
glucometer (Miles Inc, USA). Measuring of the glucose level of the fasting rats 
was conducted on days 1, 3, and 16 after NaCl 0.9% injection or streptozotocin 
50 mg/kg body weight and aquadest or mixture extract treatment at different 
doses. The blood lipid levels and blood insulin levels of the fasting rats were 
measured on day 16. All rats were observed for their body weight, food and 
water consumption on days 1, 3, and 16. Necropsy and pancreas 
immunohistopathological examinations were done on day 16 (3 rats per group). 
Before necropsy, rats were injected with euthal 200 mg/kg body weight, 
ketamine 80 mg/kg body weight, and xylazine 10 mg/kg body weight. 
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2.4 Measurement of Blood Glucose Level, Blood Insulin Level, 
and Blood Lipid Level  
Blood samples from all groups, obtained from the tail vein of the rats, were 
used for measurenment of the blood glucose levels using a single touch 
glucometer (GlucoDr kit). Measurenment of the blood insulin levels was done 
using a kit (Mercodia, Sylveniusgatan, Uppsala) and a microplate reader 
(BioRad 3550) with the enzyme linked immunosorbant assay (ELISA), while 
the blood total cholesterol, HDL and triglyserida levels were analyzed using a 
commercial kit (Roche Diagnostics GmbH, Mannheim, Germany). The blood 
lipid levels were measured using a Photometer 5010 (Robert Riele GmbH & Co 
kG).  
2.5 Eosin Haematoxylin Staining and Immunohistochemical 
Staining 
The tissue preparation was immersed in xylol solvent followed by absolute 
alcohol 95% and alcohol 70%. The obtained product was washed with flowing 
water and then immersed in dye reagent of Mayer’s haematoxylin for 5 minutes 
and then washed again. In the next step, the tissue preparation was immersed in 
acid alcohol solvent, a solution of ammonia and dye of eosin, alternately. 
Furthermore, the preparation was washed with alcohol 95%, absolute alcohol 
and xylol. The obtained preparation was observed under a light microscope to 
count the number of Langerhans islets. Photomicrographs of microscopical 
sections were taken with a Nikon Eclipse 80i DS Fi1.  
Furthermore, immunohistochemical staining was conducted to observe the 
number of pancreatic β cells. Staining was started with making the 
histopathology preparation. After deparaffinization and rehydration, the 
preparation was immersed in a phosphate buffer solution (PBS) for 2 minutes. 
Then, the preparation was added with a few drops of blocking protein and 
mouse monoclonal anti-insulin antibody and then incubated for 60 minutes. The 
preparation was immersed in PBS and added with a solution of secondary 
antibody i.e. Trek Universal Link and then immersed again in PBS, and Trek-
Avidin-HRP was added. Subsequently, the preparation was visualized using 
1.3-deaminobenzidin (DAB) and immersed in distilled water for 5 minutes and 
then given a hematoxylin dye. The last step was dehydration, clearing, 
mounting and observation under the microscope.  
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3 Results and Discussion 
3.1 The Effect of P. crocatum and C. burmannii Mixture Extract 
Treatment on Rat Body Weight  
The body weights of the rats in all groups that were given the mixture extracts 
of P. crocatum and C. burmannii on day 1 were statistically similar (see Table 
1), but they decreased after streptozotocin induction on days 3 and 16, except 
group KN. The body weights of the rats in group KP showed the highest 
reduction compared to the others (5.26% on day 3 and 10.98% on day 16 
compared to the body weight on day 1). This indicates that the P. crocatum and 
C. burmannii mixture extract treatment suppressed the reduction of the rats’ 
body weights. The 16-day treatment with various doses of P. crocatum and C. 
burmannii mixture extract administered orally to streptozotocin-induced 
diabetic rats suppressed reduction of the rats’ body weights at 2-8%. Giving hot 
water extract of mahogany bark for 13 days with doses of 250 mg/kg body 
weight also suppressed the body weight reduction of rats that were alloxan-
induced up to 8.54 % in [12]. Diabetic rats that were induced by alloxan for 10 
days showed suppression of body weight reduction up to 4.41% after being 
given 322 mg/kg body weight of P. crocatum extract in [5]. 
Table 1 Effect of 16-day treatment with P. crocatum and C. burmannii 
mixture extract on rat body weight. 
Groups Day 1 Day 3 Day 16 
KN 244.08±7.37ab 259.45±7.32b 267.55±7.08b 
KP 262.40±19.15a 248.63±20.32a 233.55±19.63a 
KDS 1 261.30±23.16a 253.43±27.74a 244.88±35.31a 
KDS 2 263.28±30.19a 259.30±18.54a 255.40±18.30a 
KDS 3 268.98±14.50a 256.30±25.02a 245,35±12.79a 
SM 269.55±30.14a 266.18±28.95a 253,15±36.89a 
 
Amounts that share the same superscript characters (a,b) are statistically similar 
at p < 0.05 (n = 4). Group KN is normal control (administered i.p. with NaCl 
0.9% and p.o. with aquadest 2 mL per day for 16 days); group KP is diabetic 
control (administered i.p. with streptozotocin 50 mg/kg body weight and p.o. 
with aquadest 2 mL per day for 16 days); groups KDS 1, KDS 2, and KDS 3 are 
mixture extract treatment at different doses (administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with extract 630 mg/kg body 
weight (KDS 1), 1260 mg/kg body weight (KDS 2), and 1890 mg/kg body 
weight (KDS 3) per day for 16 days); group SM was administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with P. crocatum extract 1350 
mg/kg body weight per day for 16 days. 
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The effect of giving mixture extract of P. crocatum and C. burmannii on the 
rats’ food consumption on day 1 in all groups was statistically similar (see 
Table 2), but it was decreased after streptozotocin induction on days 3 and 16, 
except in group KN. The highest reduction occurred in group KP (diabetic 
control – 5.10% on day 3 and 10.83% on day 16 compared to food consumption 
on day 1). Diabetic rats that were induced by alloxan for 10 days also showed 
reduced food consumption up to 34.88% after being given 800 mg/kg of 
methanol-water Coccinia indica leaves extract [13]. The lowest reduction 
occurred in group KDS 2 at a dosage of 1260 mg/kg body weight (1.27% on 
day 3 and 3.16% on day 16 compared to food consumption on day 1). This 
indicates that treatment with P. crocatum and C. burmannii mixture extract for 
16 days can maintain relatively stability of the amount of food consumption by 
the rats. This shows that P. crocatum and C. burmanni mixture extract can 
improve the condition of diabetic rats.  
Table 2 Rat food consumption for 16-day treatment with P. crocatum and C. 
burmannii mixture extract. 
Groups Day 1 Day 3 Day 16 
KN 14.65±1.3ab 15.7±1.2b 16.1±1.2b
KP 15.7±3.2a 14.9±3.4a 14.0±3.3a
KDS 1 15.7±3.9a 15.2±4.6a 14.7±5.9a
KDS 2 15.8±5.0a 15.6±3.1a 15.3±3.1a
KDS 3 16.1±2.4a 15.4±4.2a 14.7±2.1a
SM 16.1±5.0a 15.9±4.8a 15.2±6.2a
 
Amounts that share the same superscript characters (a,b) are statistically similar 
at p < 0.05 (n = 4). Group KN is normal control (administered i.p. with NaCl 
0.9% and p.o. with aquadest 2 mL per day for 16 days); group KP is diabetic 
control (administered i.p. with streptozotocin 50 mg/kg body weight and p.o. 
with aquadest 2 mL per day for 16 days); groups KDS 1, KDS 2, and KDS 3 are 
mixture extract treatment with different doses (administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with extract 630 mg/kg body 
weight (KDS 1), 1260 mg/kg body weight (KDS 2), and 1890 mg/kg body 
weight (KDS 3) per day for 16 days); group SM was administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with P. crocatum extract 1350 
mg/kg body weight per day for 16 days. 
3.2 Effect of P. crocatum and C. burmannii Mixture Extract 
Treatment on Rat Blood Glucose Levels 
Blood glucose levels were measured on days 0, 4, 9 and 15 in order to observe 
the effect of the aquadest or P. crocatum and C. burmannii mixture extract or P. 
crocatum extract administered orally to diabetic rats induced by streptozotocin. 
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Table 3 shows that on day 1, when the treatment had not yet started, the blood 
glucose levels of all the rats were significantly different (p < 0.05), while the 
range was normal (90-100 milligram/deciliter). On the third day, after induction 
with streptozotocin, the blood glucose levels of the rats had increased. The 
blood glucose levels for the other groups, i.e. groups KP, KDS 1, KDS 2, KDS 
3 and SM, had increased up to 2- to 3-fold. The increase in blood glucose levels 
of the rats on the third day, after induction with streptozotocin, was significantly 
different (p < 0.05) compared with the KN group (normal control).  
Table 3 Rat blood glucose levels for 16 days of treatment with P. crocatum 
and C. burmannii mixture extract. 
Groups Day 1 Day 3 Day 16 
KN 100.00±7.44a 100.00±5.03a 92.00±8.76a 
KP 100.50±6.56a 342.75±46.61b 383.75±73.49b 
KDS 1 104.75±16.50a 274.75±47.03b 141.00±67.19ab 
KDS 2 97.50±3.87a 308.50±19.43b 151.25±83.51a 
KDS 3 97.00±18.60a 306.25±48.49b 212.25±70.32ab 
SM 100.00±5.48a 237.50±44.47b 145.00±57.00ab 
 
Amounts that share the same superscript characters (a,b) are statistically similar 
at p < 0.05 (n = 4). Group KN is normal control (administered i.p. with NaCl 
0.9% and p.o. with aquadest 2 mL per day for 16 days); group KP is diabetic 
control (administered i.p. with streptozotocin 50 mg/kg body weight and p.o. 
with aquadest 2 mL per day for 16 days); groups KDS 1, KDS 2, and KDS 3 are 
mixture extract treatment with different doses (administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with extract 630 mg/kg body 
weight (KDS 1), 1260 mg/kg body weight (KDS 2), and 1890 mg/kg body 
weight (KDS 3) per day for 16 days); group SM was administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with P. crocatum extract 1350 
mg/kg body weight per day for 16 days. 
The blood glucose levels of the rats were reduced up to 30 to 51% after 16 days 
of treatment with various dosages of P. crocatum and C. burmannii mixture 
extract (groups KDS 1, KDS 2 and KDS 3) compared with the KP group. Then, 
the rats in groups KDS 1 and KDS 3 were able to reduce their blood glucose 
levels up to 48.69% and 30.68%, respectively, which were statistically similar 
(p < 0.05) to the blood glucose levels of the rats on day 3. However, after 16 
days of treatment, group KDS 2 was able to reduce their blood glucose levels up 
to 50.98%, which was statistically different compared with group KDS 2 after 3 
days. Nevertheless, treatment with P. crocatum extract at a dosage of 1350 
mg/kg body weight for 16 days (group SM) was able to reduce the blood 
glucose levels of the rats up to 38.95%, which was statistically similar at 
p < 0.05 compared with the blood glucose levels of the rats on day 3 (group 
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SM). This indicates that P. crocatum and C. burmannii mixture extract at a 
dosage of 1260 mg/kg body weight could reduce the blood glucose levels of the 
rats towards a normal level.  
The mixture extract of P. crocatum and C. burmannii at a dosage of 1260 
mg/kg body weight in streptozotocin-induced diabetic rats reduced the level of 
blood glucose to 50.98%. This is a sign of antihyperglycemic activity. This 
reduction indicates higher antihyperglycemic activity than from treatment with 
P. crocatum extract at a dosage of 1350 mg/kg bw (38.95%). Diabetic rats that 
were induced by alloxan for 10 days had decreased blood glucose levels up to 
10.46% after being given 322 mg/kg of P. crocatum extract [5]. This indicates 
that C. burmannii extract can increase antihyperglicemic activity. Diabetic rats 
that were induced by alloxan for 7 days had decreased blood glucose levels up 
to 73.50% after being given 0.240 mg/kg of Morinda lucida steam bark extract 
[14]. This indicates that the different species have different activity affecting 
blood glucose level reduction. This depends on the content of bioactive 
compounds in each species. The bioactive compounds in P. crocatum consist of 
alkaloid, flavonoid and tannin [5], while those in C. burmannii consist of 
cinnamaldehyde, cinnamic benzyl and eugenol [15-16]. The presence of 
bioactive compounds in the extract mixtures was able to reduce the blood 
glucose levels of the rats. This indicates that bioactive compounds can stimulate 
pancreatic β cells by releasing a large amount of insulin hormone, which brings 
glucose to the cells [17]. 
3.3 Effect of P. crocatum and C. burmannii Mixture Extract 
Treatment on Rat Insulin Levels 
The rat blood insulin levels increased up to 13 to 170% (see Table 4) after 16 
days of treatment with various doses of P. crocatum and C. burmannii mixture 
extract (groups KDS 1, KDS 2, and KDS 3). The rats in groups KDS 1, KDS 2, 
and KDS 3 were able to increase their blood insulin levels up to 50.34%, 
170.75% and 13.61%, respectively, which is statistically similar at p < 0.05 
compared with group KN (normal control) and group KP (diabetic control). The 
same pattern was observed in group SM, which was treated with P. crocatum 
extract at 1350 mg/kg body weight for 16 days. In this group, the blood insulin 
levels were increased up to 41.50%, which is statistically similar at p < 0.05 
compared with groups KN and KP. This result indicates that P. crocatum and C. 
burmannii mixture extract at a dosage of 1260 mg/kg body weight affects the 
rats blood insulin towards a normal level.  
In the present study, the mixture extract of P. crocatum and C. burmannii at 
1260 mg/kg body weight administered to streptozotocin-induced diabetic rats 
increased blood insulin levels towards a normal level. This finding is similar to 
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the results of treatment with ginseng root and green tea extract at 400 mg/kg 
body weight, which increased the blood insulin levels in streptozotocin-induced 
diabetes rats towards a normal level too. This shows that increased rat blood 
insulin levels can reduce rat blood glucose levels. The increase of the blood 
insulin levels in the test animals was caused by the capability of the bioactive 
compounds in the mixture extracts of producing regeneration of pancreatic islets 
[18]. Alkaloid compounds are known to be responsible for stimulating the 
multiplication of pre-existing islet cells [19]. 
Table 4 Effect of 16-Day treatment with P. crocatum and C. burmannii 
mixture extract on rat blood insulin levels. 
Groups Insulin (µg/L) 
KN 6.85±5.46a
KP 1.47±0.31b
KDS 1 2.21±0.41ab
KDS 2 3.98±1.54ab
KDS 3 1.67±0.23ab
SM 2.08±0.49ab
 
Amounts that share the same superscript characters (a,b) are statistically similar 
at p < 0.05 (n = 4). Group KN is normal control (administered i.p. with NaCl 
0.9% and p.o. with aquadest 2 mL per day for 16 days); group KP is diabetic 
control (administered i.p. with streptozotocin 50 mg/kg body weight and p.o. 
with aquadest 2 mL per day for 16 days); groups KDS 1, KDS 2, and KDS 3 are 
mixture extract treatment at different doses (administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with extract 630 mg/kg body 
weight (KDS 1), 1260 mg/kg body weight (KDS 2), and 1890 mg/kg body 
weight (KDS 3) per day for 16 days); group SM was administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with P. crocatum extract 1350 
mg/kg body weight per day for 16 days. 
3.4 Effect of P. crocatum and C. burmannii Mixture Extract 
Treatment on Rat Blood Lipid Levels 
Measurement of the blood lipid levels was carried out after 16 days of oral 
treatment of streptozotocin-induced diabetic rats with aquadest or P. crocatum 
and C. burmannii mixture extract or P. crocatum extract. Table 5 shows that the 
rat blood lipid levels in all groups were statistically similar at p < 0.05. 
However, the blood triglyceride level in group KP tended to increase up to 
approximately 92.46% compared to the blood triglyceride level of group KN 
(normal control). This indicates that P. crocatum and C. burmannii mixture 
extracts and P. crocatum extract could maintain the rat blood lipid levels at a 
normal level. 
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Table 5 Effect of 16-Day treatment with P. crocatum and C. burmannii 
mixture extract on rat blood lipid levels. 
Groups  Total Cholesterol (mg/dl) HDL (mg/dl) Triglyceride (mg/dl) 
KN  63.00±15.38a 61.75±9.46a 49.75±17.76a 
KP  55.75±7.68a 46.00±8.08a 95.75±37.88a 
KDS 1  70.00±5.48a 69.50±8.74a 40.00±7.39a 
KDS 2  66.75±11.95a 61.75±12.97a 52.00±11.79a 
KDS 3  48.00±6.73a 49.00±8.64a 53.50±37.19a 
SM  63.75±8.66a 58.50±12.40a 69.50±45.27a 
 
Amounts that share the same superscript characters (a,b) are statistically similar 
at p < 0.05 (n = 4). Group KN is normal control (administered i.p. with NaCl 
0.9% and p.o. with aquadest 2 mL per day for 16 days); group KP is diabetic 
control (administered i.p. with streptozotocin 50 mg/kg body weight and p.o. 
with aquadest 2 mL per day for 16 days); groups KDS 1, KDS 2, and KDS 3 are 
mixture extract treatment at different doses (administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with extract 630 mg/kg body 
weight (KDS 1), 1260 mg/kg body weight (KDS 2), and 1890 mg/kg body 
weight (KDS 3) per day for 16 days); group SM was administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with P. crocatum extract 1350 
mg/kg body weight per day for 16 days. 
3.5 Effect of P. crocatum and C. burmannii Mixture Extract 
Treatment on Number of Rat Pancreatic Islets 
To understand more about the molecular mechanism of P. crocatum and C. 
burmannii mixture extract and P. crocatum extract in reducing hyperglycemia 
via insulin production from pancreatic islets (see Figure 1), we evaluated the 
quantities of Langerhans islets and pancreatic β cells (see Table 6). 
Table 6 Effect of 16-day treatment with P. crocatum and C. burmannii mixture 
extract on rat Langerhans Islet and number of β cells. 
Groups Langerhans islets β cells 
KN 29.50±0.71a 166.00±9.90a
KP 4.50±0.71c 66.50±7.78c
KDS 1 9.00±1.41bc 112.00±7.07b
KDS 2 15.00±2.83b 143.50±10.61ab 
KDS 3 7.00±4.24bc 103.00±4.24b
SM 10.00±1.41bc 105.50±9.19b
 
Amounts that share the same superscript characters (a,b) are statistically similar 
at p < 0.05 (n = 4). Group KN is normal control (administered i.p. with NaCl 
0.9% and p.o. with aquadest 2 mL per day for 16 days); group KP is diabetic 
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control (administered i.p. with streptozotocin 50 mg/kg body weight and p.o. 
with aquadest 2 mL per day for 16 days); groups KDS 1, KDS 2, and KDS 3 are 
mixture extract treatment at different doses (administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with extract 630 mg/kg body 
weight (KDS 1), 1260 mg/kg body weight (KDS 2), and 1890 mg/kg body 
weight (KDS 3) per day for 16 days); group SM was administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with P. crocatum extract 1350 
mg/kg body weight per day for 16 days. 
 
Figure 1 Insulin immunostaining on β-cells (brown) in islets of Langerhans. 
The scale bars are 50 µm. (A) Group KN is normal control (administered i.p. 
with NaCl 0.9% and p.o. with aquadest 2 mL per day for 16 days); (B) group KP 
is diabetic control (administered i.p. with streptozotocin 50 mg/kg body weight 
and p.o. with aquadest 2 mL per day for 16 days); (C) groups KDS 1, (D) KDS 2 
and (E) KDS 3 are mixture extract treatment at different doses (administered i.p. 
with streptozotocin 50 mg/kg body weight and p.o. with extract 630 mg/kg body 
weight (KDS 1), 1260 mg/kg body weight (KDS 2), and 1890 mg/kg body 
weight (KDS 3) per day for 16 days); (F) group SM was administered i.p. with 
streptozotocin 50 mg/kg body weight and p.o. with P. crocatum extract 1350 
mg/kg body weight per day for 16 days. 
The numbers of Langerhans islets decreased up to 6.6-fold in 16 days after 
treatment with aquadest and streptozotocin induction. Nevertheless, the 
numbers of Langerhans islets increased up to 1.6- to 3.3-fold after 16 days of 
treatment with various doses of P. crocatum and C. burmannii mixture extract 
(KDS 1, KDS 2 and KDS 3). The rats in groups KDS 1 and KDS 3 were able to 
increase their numbers of Langerhans islets up to 2-fold and 1.6-fold, 
respectively, which is both statistically similar at p < 0.05 compared with group 
KP. The same pattern was observed in group SM, which was treated with P. 
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crocatum extract at 1350 mg/kg body weight for 16 days. This group was able 
to increase the number of Langerhans islets up to 2.2-fold. This increased 
number was statistically similar at p < 0.05 compared with group KP (diabetic 
control). However, group KDS 2 was able to increase their numbers of 
Langerhans islets up to 3.3-fold, which is statistically different compared with 
groups KN and KP. This indicates that the P. crocatum and C. burmannii 
mixture extract at a dosage of 1260 mg/kg body weight led the number of 
Langerhans islets towards a normal level.  
Streptozotocin can be used to induce diabetic in rats by destroying pancreatic β 
cells [20]. In the present study it was shown that P. crocatum and C. burmannii 
mixture extract at a dosage of 1260 mg/kg body weight increased the number of 
pancreatic β cells towards a normal level. This finding is similar to the results 
from Karaca, et al. [21], where diabetic rats were given an extract of ginseng at 
a dosage of 400 mg/kg body weight for 42 days and the treatment aimed at 
improving insulin-immunoreactivity showed a significant positive effect on the 
number of β cells in the Langerhans islets. The present study indicates that P. 
crocatum and C. burmanni mixture extract can reduce blood glucose levels in 
rats by enhancing the number of pancreatic β cells in order to increase the rat 
blood insulin level. 
4 Conclusion 
The present study showed that antihyperglicemic activity of P. crocatum and C. 
burmannii mixture extract enhances the number of pancreatic β cells in rats, 
which can increase the rats’ blood insulin levels, which in turn can reduce the 
rats’ blood glucose levels. In addition, P. crocatum and C. burmannii mixture 
extract can maintain blood lipid levels in rats at a normal level. Further research 
is needed to investigate the antihyperglicemic activity of the bioactive 
compounds in P. crocatum and C. burmannii mixture extract. Also, more 
information is needed about the molecular mechanism of the antihyperglicemic 
activity of P. crocatum and C. burmannii mixture extract. 
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